Pfizer Analyst Price Targets

Pfizer Inc

PFENYSE

Trade with Public

$29.44

-0.14-0.47%

最終更新: Oct 20, 6:40 AM

$29.65

0.070.24%

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

決算: Q3 2026 Q3 2026のこれから火 11 3rdの14 日後決算、マーケットオープン前。

Pfizer Analyst Price Targets

Wall Street analyst price targets and consensus rating for Pfizer (PFE).

Price Target Range — 13 Quarters

Analyst Consensus — 19 Analysts

7Buy

10Hold

2Sell

Consensus RatingNeutral# Analysts19Avg. Consensus PT$30Upside to Avg. PT+1.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	JP Morgan	Chris Schott	PT Raise	Neutral	$28→$30
Oct 8, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Neutral	$27→$28
Oct 6, 2026	Scotiabank	Louise Chen	PT Raise	Sector Outperform	$30→$33
Sep 10, 2026	HSBC	Rajesh Kumar	PT Raise	Hold	$28→$30
Aug 7, 2026	Guggenheim	Vamil Divan	PT Cut	Buy	$35→$31
Jul 13, 2026	BMO Capital	Evan David Seigerman	PT Cut	Outperform	$34→$30
Jul 13, 2026	Guggenheim	Vamil Divan	PT Cut	Buy	$36→$35
Jul 10, 2026	B of A Securities	Jason Gerberry	PT Cut	Neutral	$27→$26
Jul 8, 2026	JP Morgan	Chris Schott	PT Cut	Neutral	$30→$28
Jul 6, 2026	Cantor Fitzgerald	Carter Gould	Maintained	Neutral	$27
Jul 6, 2026	HSBC	Rajesh Kumar	Downgrade	Buy→Hold	$32→$28
Jun 10, 2026	RBC Capital	Trung Huynh	Upgrade	Underperform→Sector Perform	$25
Apr 29, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$26→$27
Apr 20, 2026	RBC Capital	Trung Huynh	Maintained	Underperform	$25
Apr 16, 2026	CICC	Jin Zhang	Initiate	Outperform	$33
Apr 13, 2026	UBS	Michael Yee	PT Raise	Neutral	$25→$27
Apr 10, 2026	Morgan Stanley	Terence Flynn	PT Raise	Equal-Weight	$27→$28
Apr 9, 2026	B of A Securities	Jason Gerberry	PT Cut	Neutral	$27→$26
Mar 24, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$35→$36
Mar 17, 2026	HSBC	Rajesh Kumar	PT Raise	Buy	$29→$32

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $28 to $30.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

Cantor Fitzgerald analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $27 to $28.

Benzinga Newsdesk

PRO
HSBC Maintains Hold on Pfizer, Raises Price Target to $30

HSBC analyst Rajesh Kumar maintains Pfizer (NYSE:PFE) with a Hold and raises the price target from $28 to $30.

Benzinga Newsdesk

PRO
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.

Avi Kapoor

Pfizer Inc

Pfizer Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PRO
JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PRO
Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PRO
HSBC Maintains Hold on Pfizer, Raises Price Target to $30

PRO
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

ニュース

パートナーシップ

ベンジンガ・グローバル

Pfizer Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PRO
JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PRO
Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PRO
HSBC Maintains Hold on Pfizer, Raises Price Target to $30

PRO
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

Pfizer Inc

Pfizer Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PROJP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PROCantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PROHSBC Maintains Hold on Pfizer, Raises Price Target to $30

PROCNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

ニュース

パートナーシップ

ベンジンガ・グローバル

Pfizer Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PROJP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PROCantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PROHSBC Maintains Hold on Pfizer, Raises Price Target to $30

PROCNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

People Also Watch

People Also Watch

PRO
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PRO
JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PRO
Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PRO
HSBC Maintains Hold on Pfizer, Raises Price Target to $30

PRO
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy

PRO
CNBC Halftime Report Final Trades: Thermo Fisher Scientific, State Street SPDR S&P Aerospace & Defense ETF, Pfizer

PRO
JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

PRO
Cantor Fitzgerald Maintains Neutral on Pfizer, Raises Price Target to $28

PRO
HSBC Maintains Hold on Pfizer, Raises Price Target to $30

PRO
CNBC Halftime Report Final Trades: Pfizer, Nvidia, Take-Two Interactive Software, Cheniere Energy